The board shall place a substance in schedule V if it finds that:

1. The substance has low potential for abuse relative to the controlled substances listed in schedule IV;

2. The substance has currently accepted medical use in treatment in the United States; and

3. The substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed in schedule IV.